20 Million Eggs Pulled from Shelves After CDC Traces Deadly Bacteria to California Facility
The CDC has linked a multistate Salmonella Enteritidis outbreak to eggs distributed by August Egg Company, resulting in 79 confirmed illnesses, including 61 hospitalizations, across seven states, with additional cases likely unreported.
On June 6, August Egg Company recalled 20.4 million eggs sold under multiple brand names in major retailers across nine states between February and May 2025.
Recalled egg cartons are identified by plant codes P-6562 or CA5330 and should be returned to the place of purchase for a full refund. Consumers are warned that infected individuals may experience severe symptoms, particularly those with weakened immune systems.The Centers for Disease Control and Prevention (CDC) has identified the source of a multistate Salmonella outbreak that has sickened dozens of Americans.
On June 6, the agency stated that its traceback data indicates that eggs "distributed by August Egg Company may be contaminated with Salmonella Enteritidis and may be making people sick."
As of June 5, 79 people have been confirmed to have contracted the specific strain of Salmonella from eggs across seven states. Six of the infected individuals had traveled to either California or Nevada in the week leading up to their illness, and 61 of those affected required hospitalization. The CDC noted that the illnesses were reported between Feb. 24, 2025, and May 17, 2025.
However, it added that the "true number of sick people in this outbreak was likely much higher than the number reported, and this outbreak may not have been limited to the states with known illnesses." This, it noted, is because many infected people recover without the need for medical intervention.
Also on June 6, the August Egg Company issued a recall for 1,700,000 dozen (or 20,400,000) brown cage-free and brown certified organic eggs. The recall noted that "healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting, and abdominal pain," though in rare circumstances, infection "can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis, and arthritis." Individuals with weakened immune systems are particularly susceptible to illness.
Related: Hospitalizations and Deaths From Contaminated Food Doubled in 2024 — Here's Everything You Need to Know
The recall stated that a set of eggs was distributed in California and Nevada between February 3 and May 15, with all featuring a sell-by date between March 4, 2025, and June 4, 2025. These eggs were available at Save Mart, FoodMaxx, Lucky, Smart & Final, Safeway, Raley's, Food 4 Less, and Ralphs.
Another set of eggs was also distributed between February 3 and May 6, with sell-by dates ranging from March 4, 2025, to June 19, 2025, to Walmart locations in California, Washington, Nevada, Arizona, Wyoming, New Mexico, Nebraska, Indiana, and Illinois.
All of the recalled egg cartons or packages include a plant code number P-6562 or CA5330. The eggs were also sold under various brand names, including Clover Organic, First Street, Nulaid, O Organics, Marketside, Raley's, Simple Truth, Sun Harvest, and Sunnyside.
'It is important to know that when our processing plant identified this concern, we immediately began diverting all eggs from the plant to an egg-breaking facility, which pasteurizes the eggs and kills any pathogens," the company shared in the recall notice. 'August Egg Company's internal food safety team is also conducting its own stringent review to identify what measures can be established to prevent this situation from recurring. We are committed to addressing this matter fully and to implementing all necessary corrective actions to ensure this does not happen again.'
It added that any consumer who has purchased the recalled eggs should return them to their place of purchase for a full refund.Recalled product: August Egg Company eggsNumber of eggs recalled: 1,700,000 dozen or 20,400,000 individual eggsReason for recall: Potential Salmonella contaminationStates affected: California, Washington, Nevada, Arizona, Wyoming, New Mexico, Nebraska, Indiana, and IllinoisNumber of illnesses: 79 confirmed cases, including 61 hospitalizationsRead the original article on Food & Wine
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
NIH scientists condemn Trump research cuts
Hundreds of staffers from across the National Institutes of Health (NIH) are speaking out against the politicization of their research and termination of their work while demanding that the drastic changes made at the agency be walked back. In a letter addressed to NIH Director Jay Bhattacharya, more than 2,000 signatories stated, 'we dissent to Administration policies that undermine the NIH mission, waste public resources, and harm the health of Americans and people across the globe.' The letter was titled 'The Bethesda Declaration' in reference to where NIH's campus is located. The signatories cited Bhattacharya's stated commitment to academic freedom that he made in April and called on him to push back against the changes Trump administration has implemented at NIH under his leadership. 'Academic freedom should not be applied selectively based on political ideology. To achieve political aims, NIH has targeted multiple universities with indiscriminate grant terminations, payment freezes for ongoing research, and blanket holds on awards regardless of the quality, progress, or impact of the science,' they wrote. They pointed to U.S. law and prior research that has shown that the participation of diverse populations in studies is necessary for NIH's work. The NIH staffers further blasted the canceling of nearly completed studies. 'Ending a $5 million research study when it is 80% complete does not save $1 million, it wastes $4 million,' they wrote. The researchers called on Bhattacharya to restore foreign collaborations with the global scientific community, put independent peer reviews back in place, bring back terminated NIH staffers and rethink the 15 percent cap on indirect study costs that the Trump administration enacted. 'Combined, these actions have resulted in an unprecedented reduction in NIH spending that does not reflect efficiency but rather a dramatic reduction in life-saving research,' they stated. 'Some may use the false impression that NIH funding is not needed to justify the draconian cuts proposed in the President's Budget. This spending slowdown reflects a failure of your legal duty to use congressionally-appropriated funds for critical NIH research.' NIH research is not solely centered in Bethesda. The agency is responsible for funding research projects across the country and abroad. Numerous lawsuits have been filed to combat the pulling back of billions of dollars in NIH funding. Last week, a federal judge allowed a suit filed by university researchers and public health groups challenging the cuts to move forward. Bhattacharya responded to the letter on the social media platform X. 'We all want @NIH to succeed and I believe that dissent in science is productive. However, the Bethesda Declaration has some fundamental misconceptions about the policy directions NIH has taken in recent months,' he wrote. Bhattacharya said the actions taken at NIH have been to 'remove ideological influence from science' and further argued the agency hasn't halted international scientific collaboration but is instead 'ensuring accountability.' 'Claims that NIH is undermining peer review are misunderstood. We're expanding access to publishing while strengthening transparency, rigor, and reproducibility in NIH-funded research,' he wrote. 'Lastly, we are reviewing each termination case carefully and some individuals have already been reinstated. As NIH priorities evolve, so must our staffing to stay mission-focused and responsibly manage taxpayer dollars.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
In letter, more than 300 scientists rebuke Trump research cuts, NIH director
June 9 (UPI) -- Hundreds of scientists via the National Institute of Health signed a published letter in protest to NIH leadership and recent cuts by the Trump administration. "We are compelled to speak up when our leadership prioritizes political moment over human safety and faithful stewardship of public resources," more than 300 scientists wrote Monday to NIH Director Jay Bhattacharya in a so-called "Bethesda Declaration" published by Stand Up For Science in rebuke to Trump administration research funding cuts and staff layoffs. They added in the letter to U.S. Health and Human Services Secretary Robert F. Kennedy Jr. and members of Congress overseeing NIH that they "dissent" to Trump's policies that "undermine" the NIH mission, "waste" public resources and harm "the health of Americans and people across the globe." In the open letter, they said the current endeavor to "Make America Healthy Again" referred to "some undefined time in the past." "Keeping NIH at the forefront of biomedical research requires our stalwart commitment to continuous improvement," the letter's writers said, adding that the life-and-death nature of NIH work "demands that changes be thoughtful and vetted." According to the letter, the Trump administration terminated at least 2,100 NIH research grants since January, totaling around $9.5 billion and contracts representing some $2.6 billion in new research. "We urge you as NIH Director to restore grants delayed or terminated for political reasons so that life-saving science can continue," the letter added in part. "This undercuts long-standing NIH policies designed to maximize return on investment by working with grantees to address concerns and complete studies," it said. It further accused the White House of creating a "culture of fear and suppression" among NIH researchers. Bhattacharya, a Stanford University professor and health researcher, called the agency the "crown jewel of American biomedical sciences" and said he had the "utmost respect" for its scientists and mission during his confirmation hearing in March. On Tuesday, Bhattacharya is scheduled to testify before the Senate's Appropriations Committee on Trump's 2026 NIH budget proposal which seeks to cut roughly 40% of NIH's $48 billion budget. "This spending slowdown reflects a failure of your legal duty to use congressionally-appropriated funds for critical NIH research," the scientists penned to Bhattacharya. The letter goes on to characterize it as "dissent" from Trump administration policy, quoting Bhattacharya during his confirmation as saying "dissent is the very essence of science." "Standing up in this way is a risk, but I am much more worried about the risks of not speaking up," says Jenna Norton, a program officer at the NIH's National Institute of Diabetes and Digestive and Kidney Diseases. "If we don't speak up, we allow continued harm to research participants and public health in America and across the globe," Norton said in a statement, adding that if others don't speak up, "we allow our government to curtail free speech, a fundamental American value."
Yahoo
an hour ago
- Yahoo
US FDA approves Merck's RSV antibody for infants
(Reuters) -The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year of age from respiratory syncytial virus during their first RSV season, the company said. The United States has seen limited supply of Sanofi and AstraZeneca's antibody Beyfortus, the only preventive shot for RSV available in the country for infants and toddlers so far. Merck's therapy, called clesrovimab and branded as Enflonsia, is a monoclonal antibody that can be administered as a single dose regardless of birth weight in healthy pre-term, full-term and at-risk infants to protect them against mild, moderate and severe RSV. RSV is a common respiratory virus that causes seasonal infections such as the flu, but is a leading cause of pneumonia and death in infants and older adults. The approval was based on results from a late-stage trial in which Enflonsia had a comparable safety profile to Swedish Orphan Biovitrum's Synagis, a monthly injection. Merck said that Enflonsia is the first and only RSV preventive option administered to infants using the same dose regardless of weight, and it told Reuters the drug will be priced at $556 per dose. Jefferies analyst Akash Tewari said last year that this is beneficial since physicians have to forecast an infant's potential weight during RSV season with Beyfortus, which makes dose ordering and inventory more complex. In the U.S., an estimated 58,000–80,000 children younger than five years are hospitalized due to RSV each year, according to the U.S. Centers for Disease Control and Prevention. The CDC currently recommends two immunization options for babies to be protected from severe RSV — an RSV vaccine given to the mother during pregnancy or an RSV antibody given to the baby. Merck expects the drug's shipments to arrive in time for the 2025-2026 RSV season. The CDC's Advisory Committee on Immunization Practices is expected to meet later this month to discuss and make recommendations for the use of Enflonsia in infants.
